查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
製药 4.0 市场，按技术、按应用、按最终用户、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1351421

製药 4.0 市场，按技术、按应用、按最终用户、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Pharma 4.0 Market, By Technology, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年，製药 4.0 市场规模达 109 亿美元，2023 年至 2030 年复合年增长率为 17.7%。

Pharma 4.0 渴望透过利用即时数据驱动的洞察、预测建模和智慧系统互连的力量来简化流程、提高产品品质并实现敏捷的决策流程。最终，它致力于开创一个以患者为中心的医疗保健时代，提供更多以患者为中心和永续的解决方案。在此过程中，它采用技术创新来有效应对製药领域不断变化的挑战和机会。

製药 4.0 市场 - 市场动态：

  • 加速药物开发和推出新疗法以推动市场需求的压力越来越大
  • 製药业在解决复杂疾病和迅速满足不断变化的患者需求方面面临越来越多的挑战。 Pharma 4.0 的出现开创了一个新时代，为药物开发、临床试验预测建模和增强的生产流程提供了更有效的途径。这种转变取决于人工智慧、机器学习和数据分析等先进技术的整合。
  • 製药 4.0 不仅可以显着节省时间和成本，还增强了业界应对突发健康危机、监管变化和消费者需求变化的适应性。因此，它营造了一种加速创新的氛围，并改善了突破性的救生疗法的可及性，为患者开创了医疗保健的新时代。

製药 4.0 市场 - 主要见解：

  • 根据我们的研究分析师分享的见解，全球製药 4.0 市场预计将显着成长，预计 2023 年至 2030 年的预测期内复合年增长率 (CAGR) 约为 18.2%。
  • 该行业的扩张受到重要因素的支撑，最显着的是加快药物开发过程并将新疗法推向市场的压力越来越大。
  • 在技​​术细分的背景下，人工智慧成为最突出的类别，占据了 2022 年的大部分市场份额。
  • 此外，在应用细分领域，临床试验将在2022年占据领先地位，凸显了Pharma 4.0在优化和加速临床研究流程方面的关键作用。
  • 从区域角度来看，北美将成为 2022 年的主要收入贡献者，反映出该地区致力于将 Pharma 4.0 作为推动创新和提高医疗保健成果的手段。

製药 4.0 市场区隔分析：

  • 全球製药 4.0 市场呈现多方面的细分结构，包括技术、应用、最终用户和地理区域作为主要部分。
  • 在技​​术分类的框架下，市场划分了三个不同的类别：云端运算、人工智慧、大数据分析和物联网。值得注意的是，人工智慧领域占据了主导地位，成为市场的主导力量。
  • 製药 4.0 利用人工智慧 (AI) 的能力，开启製药业的变革时代。人工智慧驱动的演算法有助于破解复杂的数据集、加快药物研究、提供对临床试验结果的预测性见解以及优化生产流程。人工智慧和製药 4.0 之间的这种共生关係促进了范式转变，其特点是增强决策、加强创新和采用以患者为中心的方法。最终，这种协同作用将形成一个医疗保健生态系统，不仅生产力更高，而且能够对不断变化的医疗保健需求做出高度反应。

製药4.0市场-竞争格局：

製药4.0的竞争格局是一个充满活力的舞台，其特点是老牌製药巨头和创新新创企业的融合。儘管辉瑞（Pfizer）、诺华（Novartis）和罗氏（Roche）等行业巨头投入了大量资源来拥抱数位转型，但一波在人工智慧、数据分析和自动化方面拥有专业知识的利基企业和技术新创公司正在透过引入颠覆性解决方案而崭露头角。

在这种情况下，一个值得注意的趋势是製药公司和技术提供者之间的合作精神。他们正在建立伙伴关係和联盟，培育创新文化。新兴的製药4.0市场的竞争集中在建立强大的数据平台、先进的分析能力和敏捷的製造系统。这些努力旨在透过加速药物发现、优化供应链和提供个人化医疗保健解决方案来赋予竞争优势，以满足医疗保健生态系统不断变化的需求。

目录

第 1 章：製药 4.0 市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 製药 4.0 市场片段（依技术）
    • 製药 4.0 市场片段（依应用）
    • 最终用户的製药 4.0 市场片段
    • 按国家/地区分類的製药 4.0 市场片段
    • 按地区分類的製药 4.0 市场片段
  • 竞争洞察

第 3 章：製药 4.0 主要市场趋势

  • 製药 4.0 市场驱动因素
    • 市场驱动因素的影响分析
  • 製药4.0市场限制
    • 市场限制影响分析
  • 製药4.0市场机会
  • 製药4.0市场未来趋势

第 4 章：製药 4.0 产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：製药 4.0 市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：製药 4.0 市场格局

  • 2022 年製药 4.0 市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：製药 4.0 市场 - 按技术

  • 概述
    • 按技术分類的细分市场份额分析
    • 云端运算
    • 人工智慧
    • 大数据分析
    • 物联网

第 8 章：製药 4.0 市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 药物发现与开发
    • 临床试验
    • 製造业

第 9 章：製药 4.0 市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药公司
    • 生技公司
    • CRO 和 CMO

第 10 章：製药 4.0 市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 製药 4.0 北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 製药 4.0 欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 製药4.0亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按技术）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 製药 4.0 拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按技术）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 製药 4.0 中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 製药 4.0 产业

  • 竞争仪表板
  • 公司简介
    • Pfizer Inc.
    • Roche Holding AG
    • Novartis AG
    • Johnson & Johnson
    • GlaxoSmithKline plc
    • Sanofi SA
    • AstraZeneca plc
    • Merck & Co., Inc.
    • Eli Lilly and Company
    • AbbVie Inc.
    • Boehringer Ingelheim International GmbH
    • Takeda Pharmaceutical Company Limited
    • Bristol Myers Squibb Company
    • Moderna, Inc.
    • Regeneron Pharmaceuticals, Inc.

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1656

REPORT HIGHLIGHT

Pharma 4.0 Market size was valued at USD 10,900 Million in 2022, expanding at a CAGR of 17.7% from 2023 to 2030.

Pharma 4.0 represents the integration of cutting-edge digital technologies, data analytics, robotics, and artificial intelligence into the pharmaceutical industry, aligning with the principles of the fourth industrial revolution. This transformative concept aims to revolutionize various facets of the pharmaceutical sector, encompassing drug research, development, manufacturing, and patient care. Its overarching goals include bolstering operational efficiency, expediting innovation, optimizing supply chain operations, and facilitating the implementation of personalized medicine.

Pharma 4.0 aspires to streamline processes, elevate product quality, and empower agile decision-making processes by harnessing the power of real-time data-driven insights, predictive modeling, and the interconnectivity of smart systems. Ultimately, it strives to usher in an era of healthcare that revolves around the patient, delivering more patient-centric and sustainable solutions. In doing so, it embraces technological innovations to effectively address the ever-evolving challenges and opportunities within the pharmaceutical landscape.

Pharma 4.0 Market - Market Dynamics:

  • Increasing pressure to accelerate drug development and bring new therapies to propel market demand
  • The pharmaceutical industry grapples with mounting challenges in addressing intricate diseases and meeting evolving patient needs with expediency. The advent of Pharma 4.0 has ushered in a new era, offering more efficient avenues for drug development, predictive modeling for clinical trials, and enhanced production processes. This transformation hinges on the integration of advanced technologies such as artificial intelligence, machine learning, and data analytics.
  • Pharma 4.0 not only delivers notable time and cost savings but also enhances the industry's adaptability in responding to emergent health crises, regulatory shifts, and shifting consumer demands. Consequently, it fosters a climate of accelerated innovation and improved accessibility to groundbreaking, life-saving therapies, ushering in a new era of healthcare for patients.

Pharma 4.0 Market - Key Insights:

  • According to insights shared by our research analyst, the global Pharma 4.0 market is poised for remarkable growth, with a projected Compound Annual Growth Rate (CAGR) of approximately 18.2% during the forecast period spanning from 2023 to 2030.
  • This industry's expansion is underpinned by significant factors, most notably the mounting pressure to expedite drug development processes and introduce novel therapies to market.
  • Within the context of Technology segmentation, Artificial Intelligence emerges as the standout category, capturing the majority of the market share for the year 2022.
  • Furthermore, in the realm of application segmentation, Clinical Trials takes the lead in 2022, underscoring the pivotal role of Pharma 4.0 in optimizing and expediting clinical research processes.
  • From a regional perspective, North America emerges as the primary revenue contributor in the year 2022, reflecting the region's commitment to embracing Pharma 4.0 as a means to drive innovation and enhance healthcare outcomes.

Pharma 4.0 Market- Segmentation Analysis:

  • The Global Pharma 4.0 Market exhibits a multifaceted segmentation structure, comprising Technology, Application, End-User, and Geographical Region as its primary divisions.
  • Under the umbrella of Technology classification, the market delineates three distinct categories: Cloud Computing, Artificial Intelligence, Big Data Analytics, and the Internet of Things. Remarkably, it is the Artificial Intelligence sector that asserts its dominance, emerging as the predominant force within the market.
  • Pharma 4.0 harnesses the capabilities of artificial intelligence (AI) to usher in a transformative era for the pharmaceutical sector. AI-powered algorithms are instrumental in deciphering complex datasets, expediting drug research, offering predictive insights into clinical trial outcomes, and optimizing production processes. This symbiotic relationship between AI and Pharma 4.0 fosters a paradigm shift characterized by enhanced decision-making, heightened innovation, and the adoption of patient-centric approaches. Ultimately, this synergy results in a healthcare ecosystem that is not only more productive but also highly responsive to evolving healthcare needs.

Pharma 4.0 Market- Competitive Landscape:

Pharma 4.0's competitive landscape is a dynamic arena characterized by the convergence of established pharmaceutical giants and innovative startups. While industry stalwarts like Pfizer, Novartis, and Roche commit substantial resources to embrace the digital transformation, a wave of niche players and technology startups with expertise in AI, data analytics, and automation are making their mark by introducing disruptive solutions.

In this landscape, a noteworthy trend is the collaborative spirit between pharmaceutical firms and technology providers. They are forging partnerships and alliances, fostering a culture of innovation. The competition in the burgeoning Pharma 4.0 market is centered on the establishment of robust data platforms, sophisticated analytics capabilities, and agile manufacturing systems. These endeavors aim to confer a competitive edge by accelerating drug discovery, optimizing supply chains, and delivering personalized healthcare solutions to meet the evolving needs of the healthcare ecosystem.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHARMA 4.0 MARKET KEY PLAYERS

  • Pfizer Inc.
  • Roche Holding AG
  • Novartis AG
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • AstraZeneca plc
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • Takeda Pharmaceutical Company Limited
  • Bristol Myers Squibb Company
  • Moderna, Inc.
  • Regeneron Pharmaceuticals, Inc.

GLOBAL PHARMA 4.0 MARKET, BY TECHNOLOGY

  • Cloud Computing
  • Artificial Intelligence
  • Big Data Analytics
  • Internet of Things

GLOBAL PHARMA 4.0 MARKET, BY APPLICATION

  • Drug Discovery and Development
  • Clinical Trials
  • Manufacturing

GLOBAL PHARMA 4.0 MARKET, BY END-USER

  • Pharmaceutical Companies
  • Biotechnology Companies
  • CROs and CMOs

GLOBAL PHARMA 4.0 MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Pharma 4.0 Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pharma 4.0 Market Snippet by Technology
    • 2.1.2. Pharma 4.0 Market Snippet by Application
    • 2.1.3. Pharma 4.0 Market Snippet by End-User
    • 2.1.4. Pharma 4.0 Market Snippet by Country
    • 2.1.5. Pharma 4.0 Market Snippet by Region
  • 2.2. Competitive Insights

3. Pharma 4.0 Key Market Trends

  • 3.1. Pharma 4.0 Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pharma 4.0 Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pharma 4.0 Market Opportunities
  • 3.4. Pharma 4.0 Market Future Trends

4. Pharma 4.0 Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pharma 4.0 Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Pharma 4.0 Market Landscape

  • 6.1. Pharma 4.0 Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pharma 4.0 Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 7.1.2. Cloud Computing
    • 7.1.3. Artificial Intelligence
    • 7.1.4. Big Data Analytics
    • 7.1.5. Internet of Things

8. Pharma 4.0 Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Drug Discovery and Development
    • 8.1.3. Clinical Trials
    • 8.1.4. Manufacturing

9. Pharma 4.0 Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical Companies
    • 9.1.3. Biotechnology Companies
    • 9.1.4. CROs and CMOs

10. Pharma 4.0 Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pharma 4.0 Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pharma 4.0 Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pharma 4.0 Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Pharma 4.0 Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Pharma 4.0 Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Pharma 4.0 Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. Roche Holding AG
    • 11.2.3. Novartis AG
    • 11.2.4. Johnson & Johnson
    • 11.2.5. GlaxoSmithKline plc
    • 11.2.6. Sanofi S.A.
    • 11.2.7. AstraZeneca plc
    • 11.2.8. Merck & Co., Inc.
    • 11.2.9. Eli Lilly and Company
    • 11.2.10. AbbVie Inc.
    • 11.2.11. Boehringer Ingelheim International GmbH
    • 11.2.12. Takeda Pharmaceutical Company Limited
    • 11.2.13. Bristol Myers Squibb Company
    • 11.2.14. Moderna, Inc.
    • 11.2.15. Regeneron Pharmaceuticals, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Pharma 4.0 Market: Technology Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Pharma 4.0 Market, by Technology 2018-2030 (USD Million)
  • TABLE Pharma 4.0 Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Pharma 4.0 Market, by Application 2018-2030 (USD Million)
  • TABLE Pharma 4.0 Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Pharma 4.0 Market, by End-User 2018-2030 (USD Million)
  • TABLE Pharma 4.0 Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Pharma 4.0 Market, by Region 2018-2030 (USD Million)
  • TABLE North America Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
  • TABLE North America Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
  • TABLE Europe Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
  • TABLE Latin America Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharma 4.0 Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharma 4.0 Market, by Technology, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharma 4.0 Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Pharma 4.0 Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Pharma 4.0 Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Pharma 4.0 Market share and leading players, 2022
  • FIGURE Europe Pharma 4.0 Market share and leading players, 2022
  • FIGURE Asia Pacific Pharma 4.0 Market share and leading players, 2022
  • FIGURE Latin America Pharma 4.0 Market share and leading players, 2022
  • FIGURE Middle East and Africa Pharma 4.0 Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Pharma 4.0 Market share analysis by country, 2022
  • FIGURE Germany Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Pharma 4.0 Market share analysis by country, 2022
  • FIGURE India Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Pharma 4.0 Market share analysis by country, 2022
  • FIGURE Brazil Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Pharma 4.0 Market share analysis by country, 2022
  • FIGURE Saudi Arabia Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Pharma 4.0 Market size, forecast and trend analysis, 2018 to 2030 (USD Million)